These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 22158945)

  • 1. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.
    Nasser MW; Qamri Z; Deol YS; Ravi J; Powell CA; Trikha P; Schwendener RA; Bai XF; Shilo K; Zou X; Leone G; Wolf R; Yuspa SH; Ganju RK
    Cancer Res; 2012 Feb; 72(3):604-15. PubMed ID: 22158945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling.
    Sneh A; Deol YS; Ganju A; Shilo K; Rosol TJ; Nasser MW; Ganju RK
    Breast Cancer Res Treat; 2013 Apr; 138(3):727-39. PubMed ID: 23535840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells.
    Deol YS; Nasser MW; Yu L; Zou X; Ganju RK
    J Biol Chem; 2011 Dec; 286(52):44845-54. PubMed ID: 22016394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
    Zhao H; Wilkie T; Deol Y; Sneh A; Ganju A; Basree M; Nasser MW; Ganju RK
    Mol Cancer; 2015 Jan; 14():11. PubMed ID: 25622979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.
    Sakurai M; Miki Y; Takagi K; Suzuki T; Ishida T; Ohuchi N; Sasano H
    Breast Cancer Res; 2017 Jun; 19(1):70. PubMed ID: 28629450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling.
    Liu H; Wang L; Wang X; Cao Z; Yang Q; Zhang K
    World J Surg Oncol; 2013 Apr; 11():93. PubMed ID: 23618129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene from a psoriasis susceptibility locus primes the skin for inflammation.
    Wolf R; Mascia F; Dharamsi A; Howard OM; Cataisson C; Bliskovski V; Winston J; Feigenbaum L; Lichti U; Ruzicka T; Chavakis T; Yuspa SH
    Sci Transl Med; 2010 Dec; 2(61):61ra90. PubMed ID: 21148126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment.
    Nasser MW; Wani NA; Ahirwar DK; Powell CA; Ravi J; Elbaz M; Zhao H; Padilla L; Zhang X; Shilo K; Ostrowski M; Shapiro C; Carson WE; Ganju RK
    Cancer Res; 2015 Mar; 75(6):974-85. PubMed ID: 25572331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment.
    Mishra S; Charan M; Shukla RK; Agarwal P; Misri S; Verma AK; Ahirwar DK; Siddiqui J; Kaul K; Sahu N; Vyas K; Garg AA; Khan A; Miles WO; Song JW; Bhutani N; Ganju RK
    J Exp Clin Cancer Res; 2022 Feb; 41(1):54. PubMed ID: 35135586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer.
    Syed Khaja AS; Dizeyi N; Kopparapu PK; Anagnostaki L; Härkönen P; Persson JL
    PLoS One; 2013; 8(8):e72210. PubMed ID: 23991063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation.
    Shubbar E; Vegfors J; Carlström M; Petersson S; Enerbäck C
    Breast Cancer Res Treat; 2012 Jul; 134(1):71-80. PubMed ID: 22189627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15.
    Wolf R; Howard OM; Dong HF; Voscopoulos C; Boeshans K; Winston J; Divi R; Gunsior M; Goldsmith P; Ahvazi B; Chavakis T; Oppenheim JJ; Yuspa SH
    J Immunol; 2008 Jul; 181(2):1499-506. PubMed ID: 18606705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis.
    Webb M; Emberley ED; Lizardo M; Alowami S; Qing G; Alfia'ar A; Snell-Curtis LJ; Niu Y; Civetta A; Myal Y; Shiu R; Murphy LC; Watson PH
    BMC Cancer; 2005 Feb; 5():17. PubMed ID: 15717926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer.
    Skliris GP; Lewis A; Emberley E; Peng B; Weebadda WK; Kemp A; Davie JR; Shiu RP; Watson PH; Murphy LC
    Breast Cancer Res Treat; 2007 Jul; 104(1):75-85. PubMed ID: 17009105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of ICAM-1 signaling induces psoriasin (S100A7) and MUC1 in mammary epithelial cells.
    Petersson S; Shubbar E; Yhr M; Kovacs A; Enerbäck C
    Breast Cancer Res Treat; 2011 Jan; 125(1):13-25. PubMed ID: 20217214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer.
    Straume O; Shimamura T; Lampa MJ; Carretero J; Øyan AM; Jia D; Borgman CL; Soucheray M; Downing SR; Short SM; Kang SY; Wang S; Chen L; Collett K; Bachmann I; Wong KK; Shapiro GI; Kalland KH; Folkman J; Watnick RS; Akslen LA; Naumov GN
    Proc Natl Acad Sci U S A; 2012 May; 109(22):8699-704. PubMed ID: 22589302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer.
    West NR; Watson PH
    Oncogene; 2010 Apr; 29(14):2083-92. PubMed ID: 20101226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer.
    Pond AC; Herschkowitz JI; Schwertfeger KL; Welm B; Zhang Y; York B; Cardiff RD; Hilsenbeck S; Perou CM; Creighton CJ; Lloyd RE; Rosen JM
    Cancer Res; 2010 Jun; 70(12):4868-79. PubMed ID: 20501844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.